AI reads MRI scans to spot aggressive breast cancers, no needle needed
NCT ID NCT07389200
First seen Feb 05, 2026 · Last updated May 14, 2026 · Updated 16 times
Summary
This study aims to see if MRI scans combined with artificial intelligence can predict how aggressive a breast cancer is and whether it has a protein called HER2. Currently, doctors need a needle biopsy to check for HER2, which can be uncomfortable and miss some cancer spots. The researchers will analyze MRI images from 400 breast cancer patients using machine learning to build a model that could one day replace the biopsy for this purpose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.